Quality ContChengdu Kaijie Biomedical Technology Development Co., Ltdrol
Group company: Chengdu suno Technology Development Co., Ltd. other subsidiaries: Chengdu shengnuo biopharmaceutical Co., Ltd
Chengdu shengnuo biopharmaceutical Co., Ltd., another subsidiary of Chengdu suno group, has two GMP certification of API and one production certification of preparation. 41 of other nearly 100 products are in the process of submission for audit.
Since its establishment, the company is the fastest API manufacturer to pass the SFDA review. The annual production capacity of thymopentin and somatostatin can reach 100kg and 30kg respectively;
the freeze-dried powder injection passed GMP certification in September 2009, with an annual production capacity of more than 10 million bottles.
How many companies are there in peptide api manufacturer in china? The peptide api market is very promising, and the world is encouraging the development of peptide business. There is a peptide api list on the website Biofda.com, which contains various specifications of peptide APIs for customers to choose from. Shengnuo Technology is a peptide api manufacturer located in Chengdu, a city in southwest China. Not only peptide APIs, but also carnosine custom suppliers and cosmetic peptide suppliers
There are many peptide apis manufacture in China, but they are all small-scale companies. The China peptide company such as Sinotech is a leading company in China and has a very high position.
As a Chinese peptide company, Sinotech has been working silently, hoping to become a top peptide company in the world. There are many countries producing peptides in the world, such as bulk drug substance in India, gmp custom peptide in uk, and peptide production in usa. So what is polypeptide? What kind of peptide synthesis supplier should you choose? Follow our website: www.biofda.com, here will tell you the answer.
Buy peptides online — Chengdu Kaijie Biomedical Technology Development Co., Ltd
Is a professional polypeptide drug production, research and development of high-tech enterprises
Its main industries are the production of peptide raw materials, the synthesis of peptide samples for scientific research, and the industrial production and process development of polypeptide drugs
Since its establishment in 2003, the company has developed into a world-class pharmaceutical production and R & D enterprise with a total staff of nearly 300 people and a total area of more than 12 hectares of R & D and production workshops
Its customers are mainly large-scale contracted pharmaceutical factories in North America and Europe, covering more than 1300 enterprises and R & D institutions in 69 countries around the world